Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-000324
Filing Date
2023-01-03
Accepted
2023-01-03 15:58:55
Documents
2
Group Members
MARK ANGELOYA GLOBAL INVESTMENTS II (U.S.), LPYA II GP, LPYAII GP II, LLCYORKVILLE ADVISORS GLOBAL II, LLCYORKVILLE ADVISORS GLOBAL, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm231355d6_sc13ga.htm SC 13G/A 145630
2 EXHIBIT 99.1 tm231355d6_ex99-1.htm EX-99.1 14052
  Complete submission text file 0001104659-23-000324.txt   161578
Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

EIN.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Subject) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92065 | Film No.: 23501976
SIC: 2834 Pharmaceutical Preparations